Effect of yoga as add-on therapy in migraine (CONTAIN) A randomized clinical trial

被引:29
|
作者
Kumar, Anand [1 ]
Bhatia, Rohit [1 ]
Sharma, Gautam [2 ,6 ]
Dhanlika, Dhanlika [3 ]
Vishnubhatla, Sreenivas [4 ]
Singh, Rajesh Kumar [5 ]
Dash, Deepa [5 ]
Tripathi, Manjari [5 ]
Srivastava, M. V. Padma [5 ]
机构
[1] All India Inst Med Sci, Dept Neurol, New Delhi, India
[2] All India Inst Med Sci, Dept Cardiol, New Delhi, India
[3] All India Inst Med Sci, Ctr Integrated Med & Res CIMR, New Delhi, India
[4] All India Inst Med Sci, Dept Biostat, New Delhi, India
[5] All India Inst Med Sci, New Delhi, India
[6] Cardiothorac Ctr, New Delhi, India
关键词
HEADACHES; IMPACT;
D O I
10.1212/WNL.0000000000009473
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To evaluate the effectiveness of yoga as an adjuvant to conventional medical management on clinical outcomes in patients with migraine. Methods CONTAIN was a prospective, randomized, open-label superiority trial with blinded endpoint assessment carried out at a single tertiary care academic hospital in New Delhi, India. Patients enrolled were aged 18-50 years with a diagnosis of episodic migraine and were randomized into medical and yoga groups (1:1). Randomization was computer-generated with a variable block size and concealed. A predesigned yoga intervention was given for 3 months. Outcomes were recorded by a blinded assessor. The primary endpoint was a decrease in headache frequency, headache intensity, and Headache Impact Test (HIT)-6 score. Secondary outcomes included change in Migraine Disability Assessment (MIDAS) score, pill count, and proportion of headache free patients. Results Between April 2017 and August 2018, 160 patients with episodic migraine were randomly assigned to medical and yoga groups. A total of 114 patients completed the trial. Baseline measures were comparable except for a higher mean headache frequency in the yoga group. Compared to medical therapy, the yoga group showed a significant mean delta value reduction in headache frequency (delta difference 3.53 [95% confidence interval 2.52-4.54];p< 0.0001), headache intensity (1.31 [0.60-2.01];p= 0.0004), HIT score (8.0 [4.78-11.22];p< 0.0001), MIDAS score (7.85 [4.98-10.97];p< 0.0001), and pill count (2.28 [1.06-3.51];p< 0.0003). Conclusion Yoga as an add-on therapy in migraine is superior to medical therapy alone. It may be useful to integrate a cost-effective and safe intervention like yoga into the management of migraine. Clinicaltrials.gov identifier CTRI/2017/03/008041. Classification of evidence This study provides Class III evidence that for patients with episodic migraine, yoga as adjuvant to medical therapy improves headache frequency, intensity, impact, and disability.
引用
收藏
页码:E2203 / E2212
页数:10
相关论文
共 50 条
  • [21] Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial
    Schaub, Anna-Chiara
    Schneider, Else
    Vazquez-Castellanos, Jorge F.
    Schweinfurth, Nina
    Kettelhack, Cedric
    Doll, Jessica P. K.
    Yamanbaeva, Gulnara
    Maehlmann, Laura
    Brand, Serge
    Beglinger, Christoph
    Borgwardt, Stefan
    Raes, Jeroen
    Schmidt, Andre
    Lang, Undine E.
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
  • [22] Potential Add-On Effects of Manual Therapy Techniques in Migraine Patients: A Randomised Controlled Trial
    Munoz-Gomez, Elena
    Serra-Ano, Pilar
    Molla-Casanova, Sara
    Sempere-Rubio, Nuria
    Aguilar-Rodriguez, Marta
    Espi-Lopez, Gemma, V
    Ingles, Marta
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [23] Bright Light Therapy as Add-On to Inpatient Treatment in Youth With Moderate to Severe Depression A Randomized Clinical Trial
    Legenbauer, Tanja
    Kirschbaum-Lesch, Inken
    Joerke, Carina
    Koelch, Michael
    Reis, Olaf
    Berger, Christoph
    Dueck, Alexander
    Schulte-Markwort, Michael
    Becker-Hebly, Inga
    Bienioschek, Stefanie
    Schroth, Jennifer
    Ruckes, Christian
    Deuster, Oliver
    Holtmann, Martin
    JAMA PSYCHIATRY, 2024, 81 (07) : 655 - 662
  • [24] Impact of a Course of Add-on Supervised Yoga on Cortical Inhibition in Major Depressive Disorder: A Randomized Controlled Trial
    Bhargav, Praerna H.
    Reddy, Preethi V.
    Govindaraj, Ramajayam
    Gulati, Kankan
    Ravindran, Arya
    Gayathri, D.
    Karmani, Sneha J.
    Udupa, Kaviraja
    Venkatasubramanian, Ganesan
    Philip, Mariamma
    Debnath, Monojit
    Bharath, Rose Dawn
    Sathyaprabha, T. N.
    Gangadhar, Bangalore N.
    Muralidharan, Kesavan
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2021, 66 (02): : 179 - 181
  • [25] A Randomized Clinical Trial of Elemental Zinc Add-on Therapy on Clinical Outcomes of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
    Dilmaghani, Nader Akbari
    Alani, Nadereh
    Fazeli, Sepideh
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (03): : 1595 - 1601
  • [26] Effectiveness of yoga therapy in the treatment of migraine without aura: A randomized controlled trial
    John, P. J.
    Sharma, Neha
    Sharma, Chandra M.
    Kankane, Arvind
    HEADACHE, 2007, 47 (05): : 654 - 661
  • [27] Effectiveness of integrated yoga therapy in treatment of chronic migraine: randomized controlled trial
    Sharma, N.
    Singhal, S.
    Singh, A. P.
    Sharma, C. M.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [28] Effectiveness of integrated yoga therapy in treatment of chronic migraine: randomized controlled trial
    N Sharma
    S Singhal
    AP Singh
    CM Sharma
    The Journal of Headache and Pain, 2013, 14
  • [29] Effect of add-on ramelteon therapy on sleep and circadian rhythm disruption in patients with schizophrenia: A randomized controlled trial
    Mishra, Archana
    Maiti, Rituparna
    Mishra, Biswa Ranjan
    Jena, Monalisa
    Nath, Santanu
    Sahu, Pallabi
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 31 : 109 - 118
  • [30] Randomized Controlled Crossover Trial of a New Oscillatory Device as Add-On Therapy for COPD
    Fridlender, Zvi G.
    Arish, Nissim
    Laxer, Uri
    Berkman, Neville
    Leibovitz, Allon
    Fink, Gershon
    Breuer, Raphael
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 9 (06) : 603 - 610